Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

New therapies for rare skin diseases show promise but need more research.

Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.

Tiny particles called extracellular vesicles could help with skin healing and hair growth, but more research is needed.

The woman was diagnosed with lichen sclerosus, a rare skin condition, after initial misdiagnosis and ineffective treatments.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Dupilumab for eczema may cause hair loss.

Hair loss requires customized treatments based on its various causes and types.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

Hidradenitis suppurativa is a skin disease caused by the breakdown of the skin's natural immune barriers, especially around hair follicles.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Detoxil effectively treats chronic skin conditions by improving liver detoxification and reducing symptoms.

Elderly skin care needs personalized treatment, early intervention, and integrated psychiatric care.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

Platelet-rich plasma might help treat eczema by reducing inflammation and repairing the skin.